These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 845438)

  • 21. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
    Brunner T; de Weck AL; Dahinden CA
    J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors.
    Liu MC; Proud D; Lichtenstein LM; MacGlashan DW; Schleimer RP; Adkinson NF; Kagey-Sobotka A; Schulman ES; Plaut M
    J Immunol; 1986 Apr; 136(7):2588-95. PubMed ID: 2419444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation and release of platelet-activating factor (PAF) from enriched preparations of rabbit basophils; failure of human basophils to release PAF.
    Betz SJ; Lotner GZ; Henson PM
    J Immunol; 1980 Dec; 125(6):2749-55. PubMed ID: 6159420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation between cutaneous basophil hypersensitivity and basophil sensitization.
    Lett-Brown MA; Thueson DO; Grant JA
    J Immunol; 1982 Sep; 129(3):1262-6. PubMed ID: 7108205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.
    Füreder W; Agis H; Willheim M; Bankl HC; Maier U; Kishi K; Müller MR; Czerwenka K; Radaszkiewicz T; Butterfield JH; Klappacher GW; Sperr WR; Oppermann M; Lechner K; Valent P
    J Immunol; 1995 Sep; 155(6):3152-60. PubMed ID: 7673728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of C5a-induced basophil degranulation by disodium cromoglycate.
    Golden HW; Iacuzio DA; Otterness IG
    Agents Actions; 1987 Aug; 21(3-4):371-4. PubMed ID: 2446479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-IgG1 nature of cutaneous basophil hypersensitivity factor in contact sensitivity. III. Cutaneous basophil hypersensitivity factor promotes histamine release from guinea pig bone marrow basophils after antigenic stimulation.
    Katayama I; Nishioka K; Doi T; Maeyama K; Yamatodani A
    Int Arch Allergy Appl Immunol; 1985; 77(3):353-7. PubMed ID: 2409033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low MW B-cell growth factor potentiates histamine release from human basophil leucocytes.
    Tedeschi A; Roncarolo MG; Lorini M; Miadonna A
    Immunology; 1991 Jun; 73(2):217-21. PubMed ID: 2071166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C5a induced tracheal contraction: a histamine independent mechanism.
    Regal JF; Eastman AY; Pickering RJ
    J Immunol; 1980 Jun; 124(6):2876-8. PubMed ID: 7373054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
    Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
    J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of basophil histamine release induced by pepstatin A.
    Marone G; Columbo M; Soppelsa L; Condorelli M
    J Immunol; 1984 Sep; 133(3):1542-6. PubMed ID: 6205086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement-mediated release of histamine from human leukocytes.
    Grant JA; Dupree E; Goldman AS; Schultz DR; Jackson AL
    J Immunol; 1975 Mar; 114(3):1101-6. PubMed ID: 46261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allergic bronchial asthma: eosinophil chemotaxis and antihistaminic drug modulation.
    Ventura MT; Casale G; Cenci L; Tursi A
    Allergy; 1996 Nov; 51(11):777-81. PubMed ID: 8947334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitization of circulating basophils in guinea pig recipients of passive transfer of cutaneous basophil hypersensitivity (CBH) with immune serum: antigen-specific histamine release in vitro.
    Lett-Brown MA; Mitchell EB; Askenase PW
    J Immunol; 1983 May; 130(5):2104-8. PubMed ID: 6187839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of autoimmune activation of basophils in chronic urticaria.
    Kikuchi Y; Kaplan AP
    J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria.
    Kikuchi Y; Kaplan AP
    J Allergy Clin Immunol; 2002 Jan; 109(1):114-8. PubMed ID: 11799375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged reduction in basophil counts at cutaneous basophil hypersensitivity reaction sites challenged with antigen.
    Desaules M; Askenase PW
    Immunology; 1982 Jun; 46(2):381-5. PubMed ID: 7084994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.